FromSA: Key events next week - healthcare Jan.
Post# of 36537
(Total Views: 288)
Posted On: 01/17/2020 8:38:07 AM
FromSA:
Key events next week - healthcare
Jan. 17, 2020 6:49 AM ET|About: Epizyme, Inc. (EPZM)|By: Douglas W. House, SA News Editor
Noteworthy events during the week of January 19 - 25 for healthcare investors.
TUESDAY (1/21): Generex Biotechnology (OTCQB:GNBT): Investor conference call to discuss stock sales by certain institutional investors, NGIO spinout and funding.
THURSDAY (1/23): ASCO GI Cancers Symposium, San Francisco (3 days). Forty Seven (NASDAQ:FTSV): Phase 1 data on magrolimab + cetuximab in colorectal cancer. Bellicum Pharmaceuticals (NASDAQ:BLCM): Phase 1 data on BPX-601 in pancreatic cancer.
FDA action date for Epizyme's (NASDAQ:EPZM) tazemetostat for epitheloid sarcoma.
Society for Nuclear and Molecular Medicine Mid-Winter Meeting, Tampa, FL (3 days). Progenics Pharmaceuticals (NASDAQ
GNX): Use of PyL in detection of prostate cancer.
SATURDAY (1/25): Nevro (NYSE:NVRO) investor briefing at NANS Conference.
Try Seeking Alpha PREMIUM for unlimited analysis on EPZM
6,014 people have EPZM in their portfolio and get alerts
Key events next week - healthcare
Jan. 17, 2020 6:49 AM ET|About: Epizyme, Inc. (EPZM)|By: Douglas W. House, SA News Editor
Noteworthy events during the week of January 19 - 25 for healthcare investors.
TUESDAY (1/21): Generex Biotechnology (OTCQB:GNBT): Investor conference call to discuss stock sales by certain institutional investors, NGIO spinout and funding.
THURSDAY (1/23): ASCO GI Cancers Symposium, San Francisco (3 days). Forty Seven (NASDAQ:FTSV): Phase 1 data on magrolimab + cetuximab in colorectal cancer. Bellicum Pharmaceuticals (NASDAQ:BLCM): Phase 1 data on BPX-601 in pancreatic cancer.
FDA action date for Epizyme's (NASDAQ:EPZM) tazemetostat for epitheloid sarcoma.
Society for Nuclear and Molecular Medicine Mid-Winter Meeting, Tampa, FL (3 days). Progenics Pharmaceuticals (NASDAQ
GNX): Use of PyL in detection of prostate cancer. SATURDAY (1/25): Nevro (NYSE:NVRO) investor briefing at NANS Conference.
Try Seeking Alpha PREMIUM for unlimited analysis on EPZM
6,014 people have EPZM in their portfolio and get alerts
(0)
(0)Generex Biotechnology Corp. (GNBTQ) Stock Research Links
Scroll down for more posts ▼